GA
ZSAN

Geneva Advisors’s Zosano Pharma Corporation ZSAN Stock Holding History

Geneva Advisors’s Portfolio ZSAN Stock Details ZSAN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$145K Hold
147
– – ﹤0.01% 692
2017
Q1 		$196K Sell
147
-12
-8% -$14.5K ﹤0.01% 687
2016
Q4 		$87K Buy
+159
New +$78.4K ﹤0.01% 724

Other funds holding ZSAN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LOAMU
Lombard Odier Asset Management (USA) New York $957M AUM 35.8% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ECM
Endurant Capital Management San Mateo, California $17.4M AUM 7.38% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
NC
Nexthera Capital New York $120M AUM 10.01% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Geneva Advisors's ZSAN Position: Q2 2017 in Review

Geneva Advisors held its Zosano Pharma Corporation (ZSAN) position steady in Q2 2017 at 147 shares worth $145K. The position accounts for ﹤0.01% of the portfolio, ranked #692.

Geneva Advisors first reported a position in ZSAN in Q4 2016 and has held it in 3 quarters since. The position peaked at $196K in Q1 2017. 26 funds tracked by Wall St. Rank hold ZSAN as of Q2 2017.

  • Geneva Advisors held 147 shares of Zosano Pharma Corporation worth $145K as of Q2 2017.
  • Geneva Advisors left its Zosano Pharma Corporation share count unchanged in Q2 2017.
  • Zosano Pharma Corporation made up ﹤0.01% of Geneva Advisors's portfolio in Q2 2017, its #692 holding.
  • Geneva Advisors first reported a position in Zosano Pharma Corporation in Q4 2016 and has held it in 3 quarters since.
  • Geneva Advisors's Zosano Pharma Corporation position peaked at $196K in Q1 2017.
  • 26 funds tracked by Wall St. Rank held Zosano Pharma Corporation as of Q2 2017.

Based on Geneva Advisors's 13F filing for Q2 2017, filed 7 Aug 2017.